Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis

被引：1981

作者：

Folkman, J ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 333卷 / 26期

关键词：

D O I：

10.1056/NEJM199512283332608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1757 / 1763

页数：7

共 52 条

[1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].

AIELLO, LP ;

AVERY, RL ;

ARRIGG, PG ;

KEYT, BA ;

JAMPEL, HD ;

SHAH, ST ;

PASQUALE, LR ;

THIEME, H ;

IWAMOTO, MA ;

PARK, JE ;

NGUYEN, HV ;

AIELLO, LM ;

FERRARA, N ;

KING, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487

[2]

[Anonymous], 1988, VASCULAR BIRTHMARKS

[3]

BACHARACHBUHLES M, 1994, J INVEST DERMATOL, V103, P263

[4]

Beattie G. J., 1994, ANN ONCOL, V5, p72a

[5] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].

BROOKS, PC ;

CLARK, RAF ;

CHERESH, DA .

SCIENCE, 1994, 264 (5158) :569-571

[6] THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J].

CLAPP, C ;

MARTIAL, JA ;

GUZMAN, RC ;

RENTIERDELRUE, F ;

WEINER, RI .

ENDOCRINOLOGY, 1993, 133 (03) :1292-1299

[7] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[8] CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J].

DAMERON, KM ;

VOLPERT, OV ;

TAINSKY, MA ;

BOUCK, N .

SCIENCE, 1994, 265 (5178) :1582-1584

[9] ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY [J].

DENEKAMP, J .

BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) :181-196

[10]

Drummond A. H., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P100

← 1 2 3 4 5 6 →